Showing results (71-80 of 105) with videos related to
Sort By:
Pageof 11
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2011
Pharmacokinetic-pharmacodynamic modeling of biomarker response and tumor growth inhibition to an orally available heat shock protein 90 inhibitor in a human tumor xenograft mouse modelShinji Yamazaki, Leslie Nguyen, Sylvia Vekich, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patientsDavid H Salinger, David K Blough, Paolo Vicini, et al.Scientific Reports|August 4, 2019
A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint BlockadeOleg Milberg, Chang Gong, Mohammad Jafarnejad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Pharmacokinetic model-predicted anticancer drug concentrations in human tumorsJames M Gallo, Paolo Vicini, Amy Orlansky, et al.The AAPS Journal|June 26, 2019
A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung CancerMohammad Jafarnejad, Chang Gong, Edward Gabrielson, et al.Investigative Ophthalmology & Visual Science|January 25, 2014
RTP801 gene expression is differentially upregulated in retinopathy and is silenced by PF-04523655, a 19-Mer siRNA directed against RTP801Kay D Rittenhouse, Theodore R Johnson, Paolo Vicini, et al.Clinical Pharmacology and Therapeutics|September 17, 2004
Diminishing the risk of nonrelapse mortality in hematopoietic stem cell transplantation: Prediction of exposure to the cyclophosphamide metabolite carboxyethylphosphoramide mustardRuolun Qiu, Amy Yao, Paolo Vicini, et al.Journal of Magnetic Resonance Imaging : JMRI|September 15, 2005
Mixture model approach to tumor classification based on pharmacokinetic measures of tumor permeabilityMary E Spilker, Kok-Yong Seng, Amy A Yao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2016
Found in Translation: Maximizing the Clinical Relevance of Nonclinical Oncology StudiesMary E Spilker, Xiaoying Chen, Ravi Visswanathan, et al.The Journal of Pharmacology and Experimental Therapeutics|December 2, 2011
Pharmacokinetic/pharmacodynamic modeling of crizotinib for anaplastic lymphoma kinase inhibition and antitumor efficacy in human tumor xenograft mouse modelsShinji Yamazaki, Paolo Vicini, Zhongzhou Shen, et al.Pageof 11